Search filters

List of works by Björn Tackenberg

Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial).

scientific article published on 10 January 2018

Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.

scientific article

Akinetic crisis caused by rectus sheath hematoma and acute anemia due to subcutaneous administration of apomorphine

scientific article

Anti-JC-virus antibody prevalence in a German MS cohort

scientific article

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis

scientific article published on 01 July 2019

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).

scientific article published on 4 December 2018

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA.

scientific article published on 22 December 2017

Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

scientific article

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

scientific article published on 24 May 2020

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

scientific article published on 05 May 2020

Cytokines and epilepsy

scientific article published on 08 January 2011

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.

scientific article

Deregulated Fcγ receptor expression in patients with CIDP.

scientific article

Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab

scientific article

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

scientific article

Economic Burden in a German Cohort of Patients with Multiple Sclerosis ⬇️

scientific article published on November 11, 2011

Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase III study (the PRIMA study) ⬇️

scientific article published on June 1, 2013

Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation

scientific article published on 16 November 2018

Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data

scientific article published on 01 May 2020

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis ⬇️

scientific article published on December 25, 2012

Genetic determinants of the humoral immune response in MS

scientific article published on 16 July 2020

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

scientific article published on 07 August 2020

Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy

scientific article published on 10 April 2010

IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis

scientific article published on 16 December 2019

IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis

scientific article published on 10 December 2012

Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis

scientific article

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

scholarly article

Incidence and mitigation of gastrointestinal events in patients with relapsing-remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE).

scientific article

Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus

scientific article published on 12 February 2016

Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis.

scientific article published in September 2011

Intravenous immunoglobulin maintenance treatment in myasthenia gravis: a randomized, controlled trial sample size simulation

scientific article

Is APOE ε4 associated with cognitive performance in early MS?

scientific article published on 01 May 2020

Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab

scientific article published on 13 December 2019

Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study

scientific article published on 01 April 2020

Low frequency and rare coding variation contributes to multiple sclerosis risk

MK2 and Fas receptor contribute to the severity of CNS demyelination

scientific article

Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease

scientific article published on 13 July 2015

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

scientific article published on May 2010

Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays

scientific article

NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy

scientific article published on 9 February 2008

Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients ⬇️

scientific article published on February 25, 2013

Neurofascin as a target for autoantibodies in peripheral neuropathies

scientific article published on 24 October 2012

Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).

scientific article published in April 2007

Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

scientific article published on 17 June 2016

Ocrelizumab Treatment in Patients with Primary Progressive Multiple Sclerosis: Short-term Safety Results from a Compassionate Use Programme in Germany

scientific article published on 12 August 2020

PML risk stratification using anti-JCV antibody index and L-selectin.

scientific article published on 2 October 2015

Potassium channel KIR4.1 as an immune target in multiple sclerosis

scientific article

Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod

scientific article published on 19 May 2014

Preference-based Health status in a German outpatient cohort with multiple sclerosis

scientific article published on 03 October 2013

Real-world persistence and benefit-risk profile of fingolimod over 36 months in Germany

article

Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08

scientific journal article

Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood

scientific article published on 11 December 2017

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity

scientific article

Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array

scientific article published on 26 October 2015

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity

scientific article published on 01 January 2021

Survey of diagnostic and treatment practices for multiple sclerosis in Europe, part 2: progressive MS, paediatric MS, pregnancy and general management

scientific article published on 21 January 2018

Terminal complement activation is increased and associated with disease severity in CIDP

scientific article published on 25 July 2016

The immunopathogenesis of myasthenia gravis

scientific article published on January 2008

Treatment choices and neuropsychological symptoms of a large cohort of early MS.

scientific article published in March 2018

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.

scientific article published on 24 April 2017

Whole-body vibration therapy in intensive care patients: A feasibility and safety study

scientific article

[Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany]

scientific article published on 01 December 2019

Paulina is supported by:

About Paulina

Help